Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Fully retrievable TAVR valve used for very first time | IVL for challenging coronary lesions | A new way to reach AS patients

News You Need to Know Today
Fully retrievable TAVR valve used for very first time | IVL for challenging coronary lesions | A new way to reach AS patients
Tuesday, April 8, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologists perform world’s first TAVR procedures with new fully retrievable valve

Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment. 

READ MORE >
Venus-PowerX TAVR valve developed by Venus MedTech
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists perform world’s first TAVR procedures with new fully retrievable valve

Share on Twitter Share on Facebook Share on Linkedin
Venus-PowerX TAVR valve developed by Venus MedTech
Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment. 
READ MORE >

Shockwave Medical testing new-look IVL technology on challenging coronary lesions

Care teams throughout the U.S. and U.K. are now exploring the safety and effectiveness of using Shockwave Medical's new Javelin IVL catheters to treat challenging, difficult-to-cross coronary lesions. 

READ MORE >
Shockwave Medical IVL
Share on Twitter Share on Facebook Share on Linkedin

Shockwave Medical testing new-look IVL technology on challenging coronary lesions

Share on Twitter Share on Facebook Share on Linkedin
Shockwave Medical IVL
Care teams throughout the U.S. and U.K. are now exploring the safety and effectiveness of using Shockwave Medical's new Javelin IVL catheters to treat challenging, difficult-to-cross coronary lesions. 
READ MORE >

A simple way to ensure more heart patients with severe AS receive the care they need

Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation.

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

A simple way to ensure more heart patients with severe AS receive the care they need

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation.
READ MORE >

Featured Articles

Patients requiring a permanent pacemaker after TAVR face higher long-term risk of death

As TAVR continues to grow in popularity, researchers noted, it becomes more and more important to know how different complications impact long-term outcomes.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Patients requiring a permanent pacemaker after TAVR face higher long-term risk of death

Share on Twitter Share on Facebook Share on Linkedin
As TAVR continues to grow in popularity, researchers noted, it becomes more and more important to know how different complications impact long-term outcomes.
READ MORE >

Enabling X-ray-free ablation procedures in the EP lab

Sponsored by Johnson & Johnson MedTech

Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.

READ MORE >
doctor examines patient data on their tablet
Share on Twitter Share on Facebook Share on Linkedin

Enabling X-ray-free ablation procedures in the EP lab

Sponsored by Johnson & Johnson MedTech

Share on Twitter Share on Facebook Share on Linkedin
doctor examines patient data on their tablet
Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.
READ MORE >

CMS proposes Medicare coverage for T-TEER

CMS has proposed covering tricuspid TEER for patients who present with symptomatic tricuspid regurgitation despite optimal medical therapy. The agency still has questions about the available data, however, and is seeking public comments as it makes its final decision.

READ MORE >
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes Medicare coverage for T-TEER

Share on Twitter Share on Facebook Share on Linkedin
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).
CMS has proposed covering tricuspid TEER for patients who present with symptomatic tricuspid regurgitation despite optimal medical therapy. The agency still has questions about the available data, however, and is seeking public comments as it makes its final decision.
READ MORE >

Starfish-shaped heart monitors use AI to deliver accurate results

Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.

READ MORE >
starfish heart monitor
Share on Twitter Share on Facebook Share on Linkedin

Starfish-shaped heart monitors use AI to deliver accurate results

Share on Twitter Share on Facebook Share on Linkedin
starfish heart monitor
Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.
READ MORE >

In Case You Missed It

New drug shows early potential to treat aortic stenosis in some patients without TAVR, SAVR

The drug in question, ataciguat, could help heart patients avoid aortic valve replacement—or at least put it off until later in life.

READ MORE >
heart patient
Share on Twitter Share on Facebook Share on Linkedin

New drug shows early potential to treat aortic stenosis in some patients without TAVR, SAVR

Share on Twitter Share on Facebook Share on Linkedin
heart patient
The drug in question, ataciguat, could help heart patients avoid aortic valve replacement—or at least put it off until later in life.
READ MORE >

Key trends in transcatheter tricuspid valve interventions

Steven Bolling, MD, noted that tricuspid treatments have been linked to consistent benefits in terms of quality of life. However, he said, finding clear improvements in clinical outcomes has been more challenging.

READ MORE >
Video of Steven Bolling, MD, professor of cardiac surgery, University of Michigan, explaining trends in tricuspid valve repair and replacement at CRT 2025.
Share on Twitter Share on Facebook Share on Linkedin

Key trends in transcatheter tricuspid valve interventions

Share on Twitter Share on Facebook Share on Linkedin
Video of Steven Bolling, MD, professor of cardiac surgery, University of Michigan, explaining trends in tricuspid valve repair and replacement at CRT 2025.
Steven Bolling, MD, noted that tricuspid treatments have been linked to consistent benefits in terms of quality of life. However, he said, finding clear improvements in clinical outcomes has been more challenging.
READ MORE >

Abbott makes IVL move as FDA approves new clinical trial

Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

READ MORE >
progress step forward business announce
Share on Twitter Share on Facebook Share on Linkedin

Abbott makes IVL move as FDA approves new clinical trial

Share on Twitter Share on Facebook Share on Linkedin
progress step forward business announce
Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.
READ MORE >

In Other News

First X-rays taken in space mimic historic first radiograph captured on earth

The image was taken during SpaceX’s recent Fram2 mission aboard the Crew Dragon Resilience spacecraft. 

READ MORE >
Chun Wang shares first medical radiographs captured in space.
Share on Twitter Share on Facebook Share on Linkedin

First X-rays taken in space mimic historic first radiograph captured on earth

Share on Twitter Share on Facebook Share on Linkedin
Chun Wang shares first medical radiographs captured in space.
The image was taken during SpaceX’s recent Fram2 mission aboard the Crew Dragon Resilience spacecraft. 
READ MORE >

Q&A: Rising cancer rates in young people exacerbated by provider shortage

In exclusive interviews, HealthExec spoke with the American Cancer Society about rising cancer rates, and a virtual provider service that's working to bolster struggling oncology staff.  

READ MORE >
cancer disparities health equity
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Rising cancer rates in young people exacerbated by provider shortage

Share on Twitter Share on Facebook Share on Linkedin
cancer disparities health equity
In exclusive interviews, HealthExec spoke with the American Cancer Society about rising cancer rates, and a virtual provider service that's working to bolster struggling oncology staff.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million
Cardiac robotic surgery on patient 12,500 miles away | $13M for Star Trek actor HF malpractice case | New leadless pacemaker
Supreme Court sides supports cardiac drug maker | X-ray assesses pulmonary valve regurgitation | Making cardiac data actionable
Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup